The Test Moves to the Room You Can Actually Get Into

The Alzheimer's blood test has been a story for two years now, told mostly as a research story. AAIC 2026 tells a different version of it: family doctors using the test diagnosed at 93% accuracy, against 65% without.

That gap is not a laboratory result. It is a logistics result. A family that suspects something is wrong does not start at a memory clinic: the wait is months, the referral needs a reason, and the reason is the thing they are trying to establish. They start at the appointment they can already get. Moving accuracy into that room changes who gets an answer and how long they wait for it.

The conference is careful about what is not ready. The ten-year predictive marker is framed as early results, not routine care. That distinction tends to disappear by the time a finding reaches a family, which is worth naming: a test that tells you something is coming is not the same as a test that tells you what to do about it.

For a caregiver, the practical version is small and specific. The conversation with the regular doctor is now worth having.